A. Menarini Industrie Farmaceutiche Riunite Srl - Product Pipeline Review - 2014

Global Markets Direct
April 30, 2014
43 Pages - GMD12082
$1,500.00

Summary

Global Markets Direct’s, ‘A. Menarini Industrie Farmaceutiche Riunite Srl - Product Pipeline Review - 2014’, provides an overview of the A. Menarini Industrie Farmaceutiche Riunite Srl’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of A. Menarini Industrie Farmaceutiche Riunite Srl’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of A. Menarini Industrie Farmaceutiche Riunite Srl including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of A. Menarini Industrie Farmaceutiche Riunite Srl’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the A. Menarini Industrie Farmaceutiche Riunite Srl’s pipeline products

Reasons to buy

- Evaluate A. Menarini Industrie Farmaceutiche Riunite Srl’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of A. Menarini Industrie Farmaceutiche Riunite Srl in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the A. Menarini Industrie Farmaceutiche Riunite Srl’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of A. Menarini Industrie Farmaceutiche Riunite Srl and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of A. Menarini Industrie Farmaceutiche Riunite Srl
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of A. Menarini Industrie Farmaceutiche Riunite Srl and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

'

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
A. Menarini Industrie Farmaceutiche Riunite Srl Snapshot 5
A. Menarini Industrie Farmaceutiche Riunite Srl Overview 5
Key Information 5
Key Facts 5
A. Menarini Industrie Farmaceutiche Riunite Srl - Research and Development Overview 6
Key Therapeutic Areas 6
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Combination Treatment Modalities 11
Pipeline Products - Partnered Products 12
Partnered Products/Combination Treatment Modalities 13
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline Products Glance 14
A. Menarini Industrie Farmaceutiche Riunite Srl - Late Stage Pipeline Products 14
Phase III Products/Combination Treatment Modalities 14
A. Menarini Industrie Farmaceutiche Riunite Srl - Clinical Stage Pipeline Products 15
Phase II Products/Combination Treatment Modalities 15
A. Menarini Industrie Farmaceutiche Riunite Srl - Early Stage Pipeline Products 16
Preclinical Products/Combination Treatment Modalities 16
A. Menarini Industrie Farmaceutiche Riunite Srl - Drug Profiles 17
(dexketoprofen trometamol + tramadol hydrochloride) 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
abagovomab 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
amediplase 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
ibodutant 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
sabarubicin 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
fasitibant chloride 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
nepadutant 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
ranolazine ER 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
MEN-1128 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline Analysis 28
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline Products by Target 28
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline Products by Route of Administration 30
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline Products by Molecule Type 31
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline Products by Mechanism of Action 32
A. Menarini Industrie Farmaceutiche Riunite Srl - Recent Pipeline Updates 34
A. Menarini Industrie Farmaceutiche Riunite Srl - Dormant Projects 36
A. Menarini Industrie Farmaceutiche Riunite Srl - Company Statement 37
A. Menarini Industrie Farmaceutiche Riunite Srl - Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Appendix 42
Methodology 42
Coverage 42
Secondary Research 42
Primary Research 42
Expert Panel Validation 42
Contact Us 43
Disclaimer 43

List of Tables
A. Menarini Industrie Farmaceutiche Riunite Srl, Key Information 5
A. Menarini Industrie Farmaceutiche Riunite Srl, Key Facts 5
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline by Indication, 2014 8
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline by Stage of Development, 2014 9
A. Menarini Industrie Farmaceutiche Riunite Srl - Monotherapy Products in Pipeline, 2014 10
A. Menarini Industrie Farmaceutiche Riunite Srl - Combination Treatment Modalities in Pipeline, 2014 11
A. Menarini Industrie Farmaceutiche Riunite Srl - Partnered Products in Pipeline, 2014 12
A. Menarini Industrie Farmaceutiche Riunite Srl - Partnered Products/ Combination Treatment Modalities, 2014 13
A. Menarini Industrie Farmaceutiche Riunite Srl - Phase III, 2014 14
A. Menarini Industrie Farmaceutiche Riunite Srl - Phase II, 2014 15
A. Menarini Industrie Farmaceutiche Riunite Srl - Preclinical, 2014 16
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline by Target, 2014 29
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline by Route of Administration, 2014 30
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline by Molecule Type, 2014 31
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline Products by Mechanism of Action, 2014 33
A. Menarini Industrie Farmaceutiche Riunite Srl - Recent Pipeline Updates, 2014 34
A. Menarini Industrie Farmaceutiche Riunite Srl - Dormant Developmental Projects,2014 36
A. Menarini Industrie Farmaceutiche Riunite Srl, Subsidiaries 38

List of Figures
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline by Top 10 Indication, 2014 7
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline by Stage of Development, 2014 9
A. Menarini Industrie Farmaceutiche Riunite Srl - Monotherapy Products in Pipeline, 2014 10
A. Menarini Industrie Farmaceutiche Riunite Srl - Partnered Products in Pipeline, 2014 12
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline by Top 10 Target, 2014 28
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline by Top 10 Route of Administration, 2014 30
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline by Top 10 Molecule Type, 2014 31
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline Products by Top 10 Mechanism of Action, 2014 32

$1,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Custom Research

Need a custom report
tailored to your goals and budget? 

E-mail us your project outline
or call Client Services to speak
with your industry analyst.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Discount Codes

Request Discount Codes
for reports of interest to you.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax